|
🐢
|
The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis.
10 auth.
Z. Younossi,
P. Golabi,
L. de Avila,
James M. Paik,
Manirath K. Srishord,
N. Fukui,
...
Y. Qiu,
L. Burns,
A. Afendy,
F. Nader
|
10 |
2019 |
10
🐢
|
|
🐜
|
Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease.
8 auth.
Noreen Hossain,
A. Afendy,
M. Stepanova,
F. Nader,
Manirath K. Srishord,
Nila Rafiq,
...
Z. Goodman,
Z. Younossi
|
8 |
2009 |
8
🐜
|
|
🐜
|
Effects of sofosbuvir-based treatment, with and without interferon, on outcome and productivity of patients with chronic hepatitis C.
10 auth.
Z. Younossi,
M. Stepanova,
L. Henry,
E. Gane,
I. Jacobson,
E. Lawitz,
...
D. Nelson,
L. Gerber,
F. Nader,
S. Hunt
|
7 |
2014 |
7
🐜
|
|
🐜
|
Sofosbuvir/velpatasvir improves patient-reported outcomes in HCV patients: Results from ASTRAL-1 placebo-controlled trial.
10 auth.
Z. Younossi,
M. Stepanova,
J. Feld,
S. Zeuzem,
I. Jacobson,
K. Agarwal,
...
C. Hézode,
F. Nader,
L. Henry,
S. Hunt
|
7 |
2016 |
7
🐜
|
|
🐬
|
An In-Depth Analysis of Patient-Reported Outcomes in Patients With Chronic Hepatitis C Treated With Different Anti-Viral Regimens
Z. Younossi,
M. Stepanova,
L. Henry,
F. Nader,
S. Hunt
|
7 |
2016 |
7
🐬
|
|
🐜
|
Patient‐reported outcomes in chronic hepatitis C patients with cirrhosis treated with sofosbuvir‐containing regimens
8 auth.
Z. Younossi,
M. Stepanova,
F. Nader,
I. Jacobson,
E. Gane,
D. Nelson,
...
E. Lawitz,
S. Hunt
|
7 |
2014 |
7
🐜
|
|
🐬
|
Burden of Illness and Economic Model for Patients With Nonalcoholic Steatohepatitis in the United States
Z. Younossi,
Radhika P. Tampi,
M. Priyadarshini,
F. Nader,
I. Younossi,
A. Racila
|
7 |
2019 |
7
🐬
|
|
🐬
|
Associations of chronic hepatitis C with metabolic and cardiac outcomes
Z. Younossi,
Z. Younossi,
M. Stepanova,
F. Nader,
Z. Younossi,
E. Elsheikh
|
7 |
2013 |
7
🐬
|
|
🐜
|
Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C.
8 auth.
A. Weinstein,
Jillian Kallman Price,
M. Stepanova,
L. W. Poms,
Yun Fang,
Juhi Moon,
...
F. Nader,
Z. Younossi
|
7 |
2011 |
7
🐜
|
|
🐢
|
Economic and Clinical Burden of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes in the U.S.
7 auth.
Z. Younossi,
Radhika P. Tampi,
A. Racila,
Y. Qiu,
L. Burns,
I. Younossi,
...
F. Nader
|
7 |
2019 |
7
🐢
|
|
🐜
|
Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease.
24 auth.
Z. Younossi,
M. Stepanova,
J. Ong,
Y. Yılmaz,
A. Duseja,
Yuichiro Eguchi,
M. El kassas,
M. Castellanos-Fernández,
J. George,
I. Jacobson,
...
E. Bugianesi,
V. Wong,
M. Arrese,
V. de Lédinghen,
M. Romero‐Gomez,
N. Méndez-Sánchez,
Aijaz Ahmed,
R. Wong,
G. Papatheodoridis,
L. Serfaty,
I. Younossi,
F. Nader,
M. Ziayee,
A. Afendy
|
6 |
2019 |
6
🐜
|
